Indications and uses
For the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation.
For the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. May be used as a protectant against further irritation.
To open, TWIST AND PULL TAB TO REMOVE . Instill 1 or 2 drops in the affected eye(s) as needed and discard container. *Follow your eye doctor’s instructions if you are using this product after an eye surgery (e.g., LASIK) to relieve eye dryness and discomfort.
Carboxymethylcellulose sodium 0.5%
Eye lubricant
you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
If swallowed, get medical help or contact a Poison Control Center right away.
To open, TWIST AND PULL TAB TO REMOVE .
Instill 1 or 2 drops in the affected eye(s) as needed and discard container.
*Follow your eye doctor’s instructions if you are using this product after an eye surgery (e.g., LASIK) to relieve eye dryness and discomfort.
Calcium chloride dihydrate; magnesium chloride hexahydrate; potassium chloride; purified water; sodium chloride; and sodium lactate. May contain hydrochloric acid and/or sodium hydroxide (to adjust pH).
1.800.678.1605
refresheyedrops.com
v2.0DFL0403
NDC 0023-0403-30
P
RESERVATIVE
-
FREE
Refresh
P
LUS
®
Lubricant Eye Drops
Original Strength
Dry Eye Relief
30 Vials 0.01 fl oz (0.4 mL) each Sterile
NDC 0023-0403-50
VALUE SIZE
50 Vials
PRESERVATIVE -FREE
Refresh
Plus®
Lubricant Eye Drops
Original Strength
Dry Eye Relief
50 Vials
0.01 fl oz (0.4 mL) each Sterile
NDC 0023-0403-70
VALUE SIZE
70 Vials
PRESERVATIVE -FREE
Refresh
Plus
®
Lubricant Eye Drops
Original Strength
Dry Eye Relief
70 Vials 0.01 fl oz (0.4mL) each Sterile
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0023-0403-30 | EA - Each | 0023-0403 | 1b7dba73-1c21-4d6c-95c5-36b7766aa4cc | 1 | 2012-07-24 |
| 0023-0403-50 | EA - Each | 0023-0403 | 20a7b344-7c02-4d09-b58e-5008980f2d82 | 1 | 2012-07-24 |
| 0023-0403-70 | EA - Each | 0023-0403 | 14e7ba33-8c0f-4406-a1fb-d69442f760da | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| carboxymethylcellulose sodium | ACTIVE INGREDIENT | K679OBS311 | 5 | |
| carboxymethylcellulose | ACTIVE MOIETY | 05JZI7B19X | 5 | |
| calcium chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 5 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | 5 | |
| magnesium chloride | INACTIVE INGREDIENT | 02F3473H9O | 5 | |
| potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 5 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 5 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 5 | |
| sodium lactate | INACTIVE INGREDIENT | TU7HW0W0QT | 5 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0023-0403 | 0023-0403-05, 0023-0403-30, 0023-0403-50, 0023-0403-70, 0023-0403-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | ACTIB |
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM LACTATE | TU7HW0W0QT | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 12 | 2022-06-28 | full-release | 2026-06-01 00:22:20 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| hydrochloric acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / INTRAPERITONEAL | 0.45 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / INTRAPERITONEAL | 0.45 %w/v | ||
| hydrochloric acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| hydrochloric acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| hydrochloric acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| hydrochloric acid | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / INTRAPERITONEAL | 0.45 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml | ||
| magnesium chloride | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| sodium lactate | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 | 2022-06-28 | Warnings | 0023-0403-50 0023-0403-70 0023-0403-30 0023-0403-05 0023-0403-10 0023-0403 00023040350 00023040305 00023040310 00023040370 00023040330 35d7ddb8-a31b-4cd3-a0c5-f06fa13f38fa 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.